PD-1 blockade induces responses by inhibiting adaptive immune resistance (Q29620856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

PD-1 blockade induces responses by inhibiting adaptive immune resistance (English)

2 references

PubMed

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Bartosz Chmielowski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

26

Antoni Ribas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Paul C Tumeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jennifer H Yearley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

I Peter Shintaku

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Emma J M Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lidia Robert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Marko Spasic

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gina Henry

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Voicu Ciobanu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alisha N West

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Manuel Carmona

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Christine Kivork

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Elizabeth Seja

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Grace Cherry

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Antonio J Gutierrez

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Tristan R Grogan

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Christine Mateus

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gorana Tomasic

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

John A Glaspy

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ryan O Emerson

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Harlan Robins

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Robert H Pierce

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

David A Elashoff

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Caroline Robert

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

23 February 2020

language of work or name

1 reference

30 April 2017

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

515

2 references

PubMed

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

568-571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

7528

2 references

PubMed

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

23 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Nivolumab plus ipilimumab in advanced melanoma

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

The blockade of immune checkpoints in cancer immunotherapy

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Effector memory T cells, early metastasis, and survival in colorectal cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--response

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

Using synthetic templates to design an unbiased multiplex PCR assay.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4246418

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

26 November 2018

Identifiers

3 references

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 February 2020

1020455470

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

3 references

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=25428505

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25428505%20AND%20SRC:MED&resulttype=core&format=json